Our portfolio

Flowsure

Flowsure automates urine output monitoring in hospitalized patients with catheters. By combining a low-cost, reusable hardware device with integrated software, Flowsure eliminates the need for manual measurements and data entry, improving nursing efficiency and ensuring real-time, accurate data flow into the Electronic Health Record (EHR).

This enables earlier detection of complications like sepsis or hemorrhagic shock and supports personalized therapy adjustments, particularly in heart failure care.

Industry: Medical Technology

Want to get in contact about Flowsure?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Enabling secure AI-assisted data management, analysis, visualization, sharing, and FAIR publishing.
Enabling standard spectrometers to simultaneously measure both chemical composition and particle size by integrating patented, cost-effective Optical-DOSY flow cells.
Enhancing patient care with AI-driven radiology solutions for clinical practice.

GuanaRep

Repurposing the obsolete hypertension drug Guanabenz for the treatment of Vanishing White Matter.
Enabling secure AI-assisted data management, analysis, visualization, sharing, and FAIR publishing.
Enabling standard spectrometers to simultaneously measure both chemical composition and particle size by integrating patented, cost-effective Optical-DOSY flow cells.
Enhancing patient care with AI-driven radiology solutions for clinical practice.

GuanaRep

Repurposing the obsolete hypertension drug Guanabenz for the treatment of Vanishing White Matter.